Mackenzie Financial Corp Molecular Templates, Inc. Transaction History

Mackenzie Financial Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 07, 2022	BUY	$0.68 - $11.25 $8,194 - $135,573	12,051 Added 90.07%	25,431 $19,000
Q2 2022 Aug 10, 2022	SELL	$0.81 - $3.43 $29,773 - $126,079	-36,758 Reduced 73.31%	13,380 $12,000
Q1 2020 May 14, 2020	SELL	$11.31 - $18.26 $283,225 - $457,266	-25,042 Reduced 33.31%	50,138 $666,000
Q4 2019 Feb 13, 2020	BUY	$6.44 - $14.21 $484,159 - $1.07 Million	75,180 New	75,180 $1.05 Million

499K

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Market Cap $1.69M
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.